Navigation Links
Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend
Date:11/1/2007

255 281

Total deferred credits 187,040 185,077

Capitalization

Long-term debt, net of current maturities 278,378 255,436

Class B stock options of subsidiary 1,255 1,255

Cumulative preferred shares 15,500 15,500

Cumulative preference shares - authorized

1,000,000 shares without par value;

outstanding - none - -

Common shares, par value $5 per share 149,139 147,609

Premium on common shares 107,502 99,223

Retained earnings 258,129 245,005

Accumulated other comprehensive

income (loss) 669 (1,067)

Total common equity 515,439 490,770

Total capitalization 810,572 762,961

Total $1,343,024 $1,258,650


'/>"/>
SOURCE Otter Tail Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Cancer Patient Wins Lottery
2. UK’s Health Services Totterin
3. Virus Claims Harry Potter is Dead!
4. Potter and His Pals Light Up and Get Drunk Too!
5. Childline Gears Up for Distraught Potter Fans
6. Final Potter Book Already Out on the Web?
7. Harry Potter Final Book - Prediction and Expectations
8. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
9. PM announces a new health care order for India
10. Ramdoss Announces Introduction of RCH-II
11. Britain Announces Third Transfusion Related Mad Cow Case
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3
Other Medicine News:Health News:Lowering Blood Pressure Improves Brain Hemorrhage Outcomes 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 3Health News:Smart Balance Announces Sales Organization Appointments 2Health News:Smart Balance Announces Sales Organization Appointments 3Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 2Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 3Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 4Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 5Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 6Health News:Gum Disease, HPV a Double Whammy 2Health News:Clinical trial volunteers mostly indifferent -- but not blind to -- researchers' financial conflicts 2Health News:Clinical trial volunteers mostly indifferent -- but not blind to -- researchers' financial conflicts 3
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Mathematical modeling predicts response to Herceptin 52980 1Mathematical modeling predicts response to Herceptin 52980 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 1Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 3Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 4The CLASS Act 3A Retirement In Security 52977 1The CLASS Act 3A Retirement In Security 52977 2